The Zacks Analyst Blog Highlights Home Depot, Gilead Sciences, TotalEnergies, Key Tronic and iPower

Zacks
在Zacks上打开
The Zacks Analyst Blog Highlights Home Depot, Gilead Sciences, TotalEnergies, Key Tronic and iPower

For Immediate Release

Chicago, IL – November 13, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: The Home Depot, Inc. HD, Gilead Sciences, Inc. GILD, TotalEnergies SE TTE, Key Tronic Corp. KTCC and iPower Inc. IPW.

Here are highlights from Thursday’s Analyst Blog:

Top Research Reports for Home Depot, Gilead and TotalEnergies

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including The Home Depot, Inc., Gilead Sciences, Inc., TotalEnergies SE as well as two micro-cap stocks, Key Tronic Corp. and iPower Inc. These research reports have been hand-picked from roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Today's Featured Research Reports

Home Depot’s shares have outperformed the Zacks Retail - Home Furnishings industry over the last six months (+16.1% vs. +13.5%). Per the Zacks analyst, the company benefits from its integrated retail model, digital investments, product innovations and Pro-focused initiatives. SRS expansion strengthens its professional customer ecosystem, while seamless operations support engagement and cross-selling opportunities.

However, larger discretionary projects remain subdued, while housing affordability and low home turnover constrain demand. Weather-driven repair activity also creates sales volatility.

(You can read the full research report on Home Depot here >>>)

Gilead’s shares have outperformed the Medical - Biomedical and Genetics industry over the past year (+35.5% vs. +10.9%). The Zacks analyst believes that the company benefits from its market-leading HIV franchise, supported by strong demand for Biktarvy, Descovy and newly approved Yeztugo. Robust Yeztugo uptake, potential label expansion, Trodelvy's growth and strategic acquisitions offer further diversification opportunities.

Yet, intensifying HIV competition, pricing pressure, cell therapy headwinds and pipeline setbacks pose challenges. Stable earnings estimates ahead of third-quarter results indicate limited near-term estimate movement.

(You can read the full research report on Gilead here >>>)

TotalEnergies’ shares have underperformed the Oil and Gas - Integrated - International  industry over the last six months (-3.7% vs. +6.1%). The Zacks analyst believes that geopolitical and security risks could disrupt the company’s operations, while reliance on acquired assets creates integration and execution challenges. Commodity price volatility may also pressure margins and cash flow.

However, TotalEnergies benefits from a diversified global portfolio, resilient production, expanding LNG exposure and new project start-ups. Low-carbon investments support its energy transition, while the stock has outperformed its industry.

(You can read the full research report on TotalEnergies here >>>)

Key Tronic’s shares have underperformed the Zacks Electronics - Miscellaneous Products industry over the past year (-52.9% vs. +10.3%). The Zacks analyst believes that the company faces liquidity constraints, elevated debt and supplier payment pressures. Profitability remains vulnerable to production volumes, program execution delays, customer credit exposure and inventory-related charges.

Yet manufacturing realignment, new program wins, a growing backlog and customer diversification support growth prospects. Vertical integration, capacity expansion and cost reductions could improve operating efficiency and margins.

(You can read the full research report on Key Tronic here >>>)

iPower’s shares have underperformed the Zacks Consumer Products - Discretionary industry over the past year (-100.0% vs. +24.0%). The Zacks analyst believes that the company faces declining revenues, margin pressure and an unproven return to profitability. Limited liquidity, convertible debt-related dilution risks, receivable concentration and execution challenges add uncertainty.

However, the GPM divestiture has created a leaner, asset-light business with lower operating costs and improved flexibility. Exclusive supply agreements, contracted sublease income and selective AI investments offer potential growth opportunities.

(You can read the full research report on iPower here >>>)

Free: Instant Access to Zacks' Market-Crushing Strategies

Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.

Today you can tap into those powerful strategies – and the high-potential stocks they uncover – free. No strings attached. 

Get all the details here >>

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This innovative software-as-a-service firm upped its user base +22% year over year. That rate is increasing and margins are expanding as AI efficiencies take effect. Of course, all our elite picks aren't winners, but this one could far surpass earlier Zacks' Stocks Set to Double like D-Wave Quantum, which shot up +680.1%.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Gilead Sciences, Inc. (GILD): Free Stock Analysis Report
 
The Home Depot, Inc. (HD): Free Stock Analysis Report
 
Key Tronic Corporation (KTCC): Free Stock Analysis Report
 
iPower Inc. (IPW): Free Stock Analysis Report
 
TotalEnergies SE Sponsored ADR (TTE): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research